LncRNA MALAT-1 regulates the growth of interleukin-22-stimulated keratinocytes via the miR-330-5p/S100A7 axis

References

• Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082.
   PubMedGoogle Scholar
• Torales J, Echeverría C, Barrios I, et al. Psychodermatological mechanisms of psoriasis. Dermatol Ther. 2020;33(6):e13827.
   PubMed Web of Science ®Google Scholar
• Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–994.
   PubMed Web of Science ®Google Scholar
• Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866–873.
   PubMed Web of Science ®Google Scholar
• Michalak-Stoma A, Pietrzak A, Szepietowski JC, et al. Cytokine network in psoriasis revisited. Eur Cytokine Netw. 2011;22(4):160–168.
   PubMed Web of Science ®Google Scholar
• Wawrzycki B, Pietrzak A, Grywalska E, et al. Interleukin-22 and its correlation with disease activity in plaque psoriasis. Arch Immunol Ther Exp. 2019;67(2):103–108.
   PubMed Web of Science ®Google Scholar
• Wolk K, Witte E, Wallace E, et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol. 2006;36(5):1309–1323.
   PubMed Web of Science ®Google Scholar
• Van Belle AB, de Heusch M, Lemaire MM, et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. JI. 2012;188(1):462–469.
   Google Scholar
• Shen H, Zeng B, Wang C, et al. MiR-330 inhibits IL-22-induced keratinocyte proliferation through targeting CTNNB1. Biomed Pharmacother. 2017;91:803–811.
   PubMed Web of Science ®Google Scholar
• Boniface K, Bernard FX, Garcia M, et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005;174(6):3695–3702.
   PubMed Web of Science ®Google Scholar
• Wahlestedt C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov. 2013;12(6):433–446.
   PubMed Web of Science ®Google Scholar
• Zou Y, Xu S, Xiao Y, et al. Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation. J Clin Invest. 2018;128(10):4510–4524.
   PubMed Web of Science ®Google Scholar
• Zhuo Q, Wei L, Yin X, et al. LncRNA ZNF667-AS1 alleviates rheumatoid arthritis by sponging miR-523-3p and inactivating the JAK/STAT signalling pathway. Autoimmunity. 2021;54(7):406–409.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Zhao F, Liu C, et al. LncRNA FOXD2-AS1 promotes cell proliferation and invasion of fibroblast-like synoviocytes by regulation of miR-331-3p/PIAS3 pathway in rheumatoid arthritis. Autoimmunity. 2021;54(5):254–263.
   PubMed Web of Science ®Google Scholar
• Gao J, Chen F, Hua M, et al. Knockdown of lncRNA MIR31HG inhibits cell proliferation in human HaCaT keratinocytes. Biol Res. 2018;51(1):30.
   PubMedGoogle Scholar
• Li S, Zhu X, Zhang N, et al. LncRNA NORAD engages in psoriasis by binding to miR-26a to regulate keratinocyte proliferation. Autoimmunity. 2021;54(3):129–137.
   PubMed Web of Science ®Google Scholar
• Duan Q, Wang G, Wang M, et al. LncRNA RP6-65G23.1 accelerates proliferation and inhibits apoptosis via p-ERK1/2/p-AKT signaling pathway on keratinocytes. J Cell Biochem. 2020;121(11):4580–4589.
   PubMed Web of Science ®Google Scholar
• Jalali S, Bhartiya D, Lalwani MK, et al. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLOS One. 2013;8(2):e53823.
   PubMed Web of Science ®Google Scholar
• Li GQ, Fang YX, Liu Y, et al. MALAT1-Driven inhibition of wnt signal impedes proliferation and inflammation in Fibroblast-Like synoviocytes through CTNNB1 promoter methylation in rheumatoid arthritis. Hum Gene Ther. 2019;30(8):1008–1022.
   PubMed Web of Science ®Google Scholar
• Lu X, Chen D, Yang F, et al. Quercetin inhibits epithelial-to-Mesenchymal transition (EMT) process and promotes apoptosis in prostate cancer via downregulating lncRNA MALAT1. Cancer Manag Res. 2020;12:1741–1750.
   PubMed Web of Science ®Google Scholar
• Gao F, Tan Y, Luo H. MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL. Braz J Med Biol Res. 2020;53(5):e9292.
   PubMed Web of Science ®Google Scholar
• Elamir AM, Shaker OG, El-Komy MH, et al. The role of LncRNA MALAT-1 and MiRNA-9 in psoriasis. Biochem Biophys Rep. 2021;26:101030.
   PubMedGoogle Scholar
• Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008;9(3):219–230.
   PubMed Web of Science ®Google Scholar
• Liu Q, Wu DH, Han L, et al. Roles of microRNAs in psoriasis: immunological functions and potential biomarkers. Exp Dermatol. 2017;26(4):359–367.
   PubMed Web of Science ®Google Scholar
• Hawkes JE, Nguyen GH, Fujita M, et al. microRNAs in psoriasis. J Invest Dermatol. 2016;136(2):365–371.
   PubMed Web of Science ®Google Scholar
• Lu J, Xu X, Li Y, et al. CircRAB3B suppresses proliferation, motility, cell cycle progression and promotes the apoptosis of IL-22-induced keratinocytes depending on the regulation of miR-1228-3p/PTEN axis in psoriasis. Autoimmunity. 2021;54(5):303–312.
   PubMed Web of Science ®Google Scholar
• Li C, Wang Z, Zhang J, et al. Crosstalk of mRNA, miRNA, lncRNA, and circRNA and their regulatory pattern in pulmonary fibrosis. Mol Ther Nucleic Acids. 2019;18:204–218.
   PubMedGoogle Scholar
• Bayoumi AS, Sayed A, Broskova Z, et al. Crosstalk between long noncoding RNAs and MicroRNAs in health and disease. Int J Mol Sci. 2016;17(3):356.
   PubMed Web of Science ®Google Scholar
• Batycka-Baran A, Baran W, Nowicka-Suszko D, et al. Serum concentration and skin expression of S100A7 (psoriasin) in patients suffering from hidradenitis suppurativa. Dermatology (Basel, Switzerland). 2021;237(5):733–739.
   PubMedGoogle Scholar
• Madsen P, Rasmussen HH, Leffers H, et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol. 1991;97(4):701–712.
   PubMed Web of Science ®Google Scholar
• Ekman AK, Vegfors J, Eding CB, et al. Overexpression of psoriasin (S100A7) contributes to dysregulated differentiation in psoriasis. Acta Derm Venereol. 2017;97(4):441–448.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Wang H, Wang C, et al. miR-203 promotes HaCaT cell overproliferation through targeting LXR-α and PPAR-γ. Cell Cycle (Georgetown, Tex.). 2020;19(15):1928–1940.
   PubMed Web of Science ®Google Scholar
• Jiang L, Lai YK, Zhang J, et al. Targeting S100P inhibits Colon cancer growth and metastasis by lentivirus-mediated RNA interference and proteomic analysis. Mol Med. 2011;17:709–716.
   PubMed Web of Science ®Google Scholar
• Yang S, Liu J, Jiao J, et al. Ar-Turmerone exerts anti-proliferative and anti-inflammatory activities in HaCaT keratinocytes by inactivating hedgehog pathway. Inflammation. 2020;43(2):478–486.
   PubMed Web of Science ®Google Scholar
• Tu K, Liu Z, Yao B, et al. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma. Int J Oncol. 2016;48(3):965–974.
   PubMed Web of Science ®Google Scholar
• Donato L, Scimone C, Rinaldi C, et al. Stargardt phenotype associated with two ELOVL4 promoter variants and ELOVL4 downregulation: new possible perspective to etiopathogenesis? Invest Ophthalmol Vis Sci. 2018;59(2):843–857.
   PubMed Web of Science ®Google Scholar
• Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Phys. 2000;182(3):311–322.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yin M, Zhang LJ. Keratin 6, 16 and 17-Critical barrier alarmin molecules in skin wounds and psoriasis. Cells. 2019;8(8):807.
   PubMed Web of Science ®Google Scholar
• Atianand MK, Fitzgerald KA. Long non-coding RNAs and control of gene expression in the immune system. Trends Mol Med. 2014;20(11):623–631.
   PubMed Web of Science ®Google Scholar
• Yan J, Song J, Qiao M, et al. Long noncoding RNA expression profile and functional analysis in psoriasis. Mol Med Rep. 2019;19(5):3421–3430.
   PubMed Web of Science ®Google Scholar
• Yang H, Liang N, Wang M, et al. Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus. Oncotarget. 2017;8(44):77400–77406.
   PubMedGoogle Scholar
• Di Nuzzo S, Sylva-Steenland RM, Koomen CW, et al. Exposure to UVB induces accumulation of LFA-1+ T cells and enhanced expression of the chemokine psoriasin in normal human skin. Photochem Photobiol. 2000;72(3):374–382.
   PubMed Web of Science ®Google Scholar
• D'Amico F, Skarmoutsou E, Granata M, et al. S100A7: a rAMPing up AMP molecule in psoriasis. Cytokine Growth Factor Rev. 2016;32:97–104.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Yu Q, Gong Y, et al. Construction of a lncRNA-miRNA-mRNA network to determine the regulatory roles of lncRNAs in psoriasis. Exp Ther Med. 2019;18(5):4011–4021.
   PubMed Web of Science ®Google Scholar
• Kim BK, Yoo HI, Choi K, et al. Regulation of srpr expression by miR-330-5p controls proliferation of mouse epidermal keratinocyte. PLOS One. 2016;11(10):e0164896.
   PubMed Web of Science ®Google Scholar
• Luo M, Huang P, Pan Y, et al. Weighted gene coexpression network and experimental analyses identify lncRNA SPRR2C as a regulator of the IL-22-stimulated HaCaT cell phenotype through the miR-330/STAT1/S100A7 axis. Cell Death Dis. 2021;12(1):86.
   PubMed Web of Science ®Google Scholar